http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#Head
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#assertion
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#provenance
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#pubinfo
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#assertion
http://purl.obolibrary.org/obo/DOID_115
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_115
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00727
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association
http://www.w3.org/2000/01/rdf-schema#label
"Nitroglycerin in 5% Dextrose Injection is contraindicated in patients who are allergic to it. In patients with pericardial tamponade, restrictive cardiomyopathy, or constrictive pericarditis, cardiac output is dependent upon venous return. Intravenous nitroglycerin is contraindicated in patients with these conditions. Nitroglycerin is also contraindicated in patients with increased intracranial pressure. Do not use Nitroglycerin in 5% Dextrose Injection in patients who are taking certain drugs for erectile dysfunction (phosphodiesterase inhibitors) such as sildenafil, tadalafil, or vardenafil. Concomitant use can cause severe hypotension, syncope, or myocardial ischemia. Do not use Nitroglycerin in 5% Dextrose Injection in patients who are taking the soluble guanylate cyclase stimulator riociguat. Concomitant use can cause hypotension."
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#association
https://w3id.org/biolink/vocab/relation
https://schema.org/MedicalContraindication
https://identifiers.org/drugbank:DB00727
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#provenance
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#pubinfo
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#sig
http://purl.org/nanopub/x/hasSignature
JqtSpnJRzrbHAcHtc6npZZHAbCRlLOH/OFVaiaqachemZF0xLsLBULKT3TlO5lCf46DKDfLofrIdXoTv29rQr+gfQyKBBIt3+TiHSA0WDheVtgA/vkAOnUo5erEVzLUZENuApZa56uySiUzrr4xHHwRq9q7MSqBXhcH+pcZ5u0Y=
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA
http://purl.org/dc/terms/created
2021-08-23T18:47:41.852+02:00
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAo3thcFqqTJVg7kPxBtIng4Ierr0WBnx7850JkSwzckA
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY